Cannpal has first mover advantage in the $67bn"hidden gem"animal health market - a podcast by Stockhead
from 2020-08-21T16:02
::
::
This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1).
Further episodes of The Health Kick Podcast with Tim Boreham
Further podcasts by Stockhead
Website of Stockhead